Protagonist Therapeutics
Stock Forecast, Prediction & Price Target

Protagonist Therapeutics (PTGX) stock Price Target by analysts

Last Year
Average Price Target

$57.33

Potential upside: 2.01%

Based on 3 analysts

Protagonist Therapeutics price prediction

Strike.market

What is Protagonist Therapeutics stock analysts` prediction?

Protagonist Therapeutics stock forecast: Based on 3 Wall Street analysts` predicted price targets for Protagonist Therapeutics in the last 3 months, the avarage price target is $57.33, with a high forecast of $NaN. The average price target represents a 2.01% change from the last price of $56.2.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Protagonist Therapeutics stock Price Target by analysts

Full breakdown of analysts given Protagonist Therapeutics price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
Etzer Darout
BMO Capital
0%
0/1
9 months ago $62 10.32% upside $41.68 StreetInsider
Previous targets (0)
Srikripa Devarakonda
Truist Financial
0%
0/1
10 months ago $60 6.76% upside $46.46 StreetInsider
Previous targets (0)
Douglas Tsao
H.C. Wainwright
0%
0/2
12 months ago $50 -11.03% downside $45.08 StreetInsider
Previous targets (1)
Douglas Tsao
H.C. Wainwright
0%
0/2
about 1 year ago $38 -32.38% downside $32.86 StreetInsider
Previous targets (1)
Yasmeen Rahimi
Piper Sandler
0%
0/1
over 3 years ago $35 -37.72% downside $8.61 TheFly
Previous targets (0)

Protagonist Therapeutics Financial Estimates

Protagonist Therapeutics Revenue Estimates

Protagonist Therapeutics EBITDA Estimates

Protagonist Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$27.35M
 
N/A
$26.58M
 
-2.83%
$60M
 
125.72%
Avg: $93.78M
Low: $11.99M
High: $263.98M
avg. 56.3%
Avg: $145.61M
Low: $108.84M
High: $212.54M
avg. 55.27%
Avg: $151.62M
Low: $113.34M
High: $221.32M
avg. 4.13%
Avg: $293.24M
Low: $219.20M
High: $428.04M
avg. 93.39%
Net Income
 
% change YoY
$-122.62M
 
N/A
$-123.41M
 
-0.64%
$-78.95M
 
36.02%
Avg: $-34.35M
Low: $-194.13M
High: $98.76M
avg. 56.48%
Avg: $-50.55M
Low: $-138.50M
High: $26.67M
avg. -47.13%
Avg: $-47.68M
Low: $-76.17M
High: $-32.02M
avg. 5.67%
Avg: $55.91M
Low: $37.55M
High: $89.32M
avg. 217.26%
EBITDA
 
% change YoY
$-125.55M
 
N/A
$-131.37M
 
-4.63%
$-90.34M
 
31.23%
Avg: $-93.78M
Low: $-263.98M
High: $-11.99M
avg. -3.80%
Avg: $-145.61M
Low: $-212.54M
High: $-108.84M
avg. -55.27%
Avg: $-151.62M
Low: $-221.32M
High: $-113.34M
avg. -4.13%
Avg: $-293.24M
Low: $-428.04M
High: $-219.20M
avg. -93.39%
EPS
 
% change YoY
-$2.65
 
N/A
-$2.52
 
4.90%
-$1.39
 
44.84%
Avg: -$1.37
Low: -$3.42
High: $1.74
avg. 1.35%
Avg: -$0.99
Low: -$2.44
High: $0.47
avg. 28.16%
Avg: -$0.84
Low: -$1.34
High: -$0.56
avg. 14.72%
Avg: $0.99
Low: $0.66
High: $1.57
avg. 217.26%
Operating Expenses
 
% change YoY
$153.20M
 
N/A
$157.95M
 
3.10%
$153.65M
 
-2.72%
Avg: $1.34B
Low: $171.77M
High: $3.77B
avg. 773.70%
Avg: $2.08B
Low: $1.55B
High: $3.04B
avg. 55.27%
Avg: $2.17B
Low: $1.62B
High: $3.16B
avg. 4.13%
Avg: $4.19B
Low: $3.13B
High: $6.12B
avg. 93.39%

FAQ

What is Protagonist Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 58.07% in 2025-2028.

We have gathered data from 4 analysts. Their low estimate is -194.13M, average is -34.35M and high is 98.76M.

What is Protagonist Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 52.27% in 2025-2028.

We have gathered data from 4 analysts. Their low revenue estimate is $11.99M, average is $93.78M and high is $263.98M.

What is Protagonist Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 65.37% in 2025-2028.

We have gathered data from 4 analysts. Their low earnings per share estimate is -$3.42, average is -$1.37 and high is $1.74.

What is the best performing analyst?

In the last twelve months 3 analysts have been covering Protagonist Therapeutics stock. The most successful analyst is Etzer Darout.